Bengt Glimelius
Scientific Advisory Board Member
Pharmaceutical Sciences
PledPharma AB
Sweden
Biography
Professor Emeritus in oncology at the University of Uppsala and Consultant at the University hospital. Between 1998 and 2014 he was also professor at Karolinska Institutet, Stockholm and consultant at the Karolinska University Hospital. He has been responsible for the care of patients with gastrointestinal cancer at the hospitals until his retirement in 2014. Professor Glimelius main research areas deal with tumour biology, gastrointestinal cancer, malignant lymphomas, radiotherapy and psychosocial care. In gastrointestinal cancer and malignant lymphomas he has been the principal or co-investigator of numerous trials. He has published more than 600 research articles and chapters in different textbooks within the research areas, made important contributions to the benefit of many patients and directed about 50 doctoral students to their PhD theses. Professor Glimelius has lectured at many international conferences, chaired several consensus conferences, official investigations, been a member of many scientific councils evaluating research proposals and projects. He is the Chief Editor of Acta Oncologica and member of the Editorial Board of several scientific journals. He was the vice chairman for 6 years of the Research Council, Swedish Cancer Society. He has also received several awards and honours.
Research Interest
Pharmaceutical Sciences, Lipid Technologies, Pharmaceutical formulations etc.